Articles written by Business Wire - Benzinga

Tornado Recovery: U-Haul Offers 30 Days Free Storage in 3 States

Friday's storms have created a need for disaster relief across parts of the Midwest U-Haul® has made 24 Company stores across three states available to help storm victims with 30 days of free self-storage and

SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Sana Biotechnology, Inc. (NASDAQ:SANA) securities between March 17,

Clover Expands Commitment to the Restaurant Industry with the Launch of Clover Hospitality by BentoBox

Live from the 2025 National Restaurant Association Show, the Top-of-the-Line Solution Proves There's a Clover for Every Restaurant Clover, the world's smartest point-of-sale solution, under parent company, Fiserv,

ZYXI Deadline: Rosen Law Firm Urges Zynex, Inc. (NASDAQ: ZYXI) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Zynex, Inc. (NASDAQ:ZYXI) between March 13, 2023 and March 11, 2025.

Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia

Preclinical research demonstrates that a single administration of BE-102 provides continuous secretion of active alkaline phosphatase (ALP) in vivo out to 6 months No safety findings observed in long-term

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

– Analysis Presented at the Heart Failure 2025 Congress Supports Primary Findings, Highlighting Impact of AMVUTTRA, which Delivers Rapid Knockdown of Transthyretin – – Additional 42-Month Data Reinforce Vutrisiran's

Rocket Lab Successfully Launches Third Mission for iQPS in Multi-Launch Contract, Sets Schedule For the Next iQPS Mission

Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today successfully launched its third mission for Japanese customer, Institute for Q-shu Pioneers

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer's Disease

—First Blood-Based In-Vitro Diagnostic Test to Receive FDA Clearance for Patients Being Assessed for Alzheimer's Disease. — —Availability of Accurate, Accessible, Blood-Based Diagnostic Tests Will Aid in Development

John Bryson, Former Edison International Chairman and CEO, Dies at 81

Successfully Led Company Through California Electricity Crisis in Early 2000s Remarkable Career Spanned Environmental Activism and Public Service The entire Edison International, Southern California Edison and Trio

NV5 GLOBAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NV5 Global, Inc. - NVEE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of NV5 Global, Inc. (NASDAQ:NVEE) to Acuren Corporation

CHARTER COMMUNICATIONS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Charter Communications, Inc. - CHTR

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Charter Communications, Inc. (NASDAQ:CHTR) and Cox

FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues Lead Plaintiff Search for Iovance Biotherapeutics, Inc. (IOVA) Securities Fraud Class Action

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have until July 15, 2025 to file lead

Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors

Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and

Strategic Storage Trust VI, Inc. Reports First Quarter 2025 Results

- Total revenues increased 11.1% compared to the same period in 2024. - Increased Same-Store Revenues by 6.8% for the Quarter. - Increased Same-Store Net Operating Income ("NOI") by 13.6% for the Quarter. -

Port Houston Regular Commission Meeting

to Be Held on Tuesday, May 20, 2025 The Port Commission of the Port of Houston Authority will hold its Regular Monthly Meeting on Tuesday, May 20, 2025, beginning at 9:15 a.m. in the boardroom of the Port Houston

Rosen Law Firm Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation – SLQT

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE:SLQT) resulting from allegations that SelectQuote

DNUT CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Krispy Kreme, Inc.

The Law Offices of Frank R.

CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder

Securities Fraud Investigation Into UroGen Pharma Ltd. (URGN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R.

Rosen Law Firm Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation – GOCO

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ:GOCO) resulting from allegations that GoHealth may